DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



An Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults

Information source: Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Polypharmacy; Incontinence; Insomnia; Anxiety

Intervention: knowledge transfer tool (Behavioral)

Phase: Phase 4

Status: Terminated

Sponsored by: Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

Official(s) and/or principal investigator(s):
Cara Tannenbaum, MD, Principal Investigator, Affiliation: Centre de recherche de l'Institut universitaire de gériatrie de Montréal

Summary

An educational intervention targeting community-dwelling older adults will lead to a reduction in potentially inappropriate prescriptions (e. g. benzodiazepines, oxybutynin). Cessation of potentially inappropriate medications (e. g. benzodiazepines, oxybutynin)will lead to improved cognitive outcomes in older adults.

Clinical Details

Official title: The Patient as a Driver of Change: an Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Primary outcome: Complete discontinuation of the targeted potentially inappropriate medication (e.g. benzodiazepines, oxybutynin)

Secondary outcome:

Cognitive function

Sleep efficiency

incontinence-related self-efficacy

frequency of urinary incontinence episodes

Detailed description: This study tests the effectiveness of a knowledge transfer tool for empowering patients to engage in collaborative discontinuation of potentially inappropriate medication with their pharmacist and/or physician

Eligibility

Minimum age: 65 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- 65 year old human adults

- who fill a prescription for at least 5 medications

- community dwelling

- chronic use (3 months or longer) of at least one potentially inappropriate medication

(e. g. benzodiazepine, oxybutynin) Exclusion Criteria:

- patients with severe mental illness, dementia and epilepsy

- concomitant consumption of any other antipsychotic medication (including lithium,

olanzapine, clozapine, quetiapine, risperidone, haloperidol etc.)

- concomitant consumption of any antiepileptic (including carbamazepine, valproate,

gabapentin, lamotrigine, topiramate, oxcarbazepine etc.)

- concomitant consumption of a cholinesterase inhibitor or memantine

Locations and Contacts

Le Groupe Jean Coutu Inc., Longueuil, Quebec J4G 1S8, Canada
Additional Information

Starting date: June 2010
Last updated: May 14, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017